Navigation Links
Global Markets for Catheters
Date:3/22/2012

NEW YORK, March 22, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Markets for Catheters

http://www.reportlinker.com/p0801348/Global-Markets-for-Catheters.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply

 

INTRODUCTION

 

STUDY GOALS AND OBJECTIVES

 

BCC Research's goal in conducting this study was to determine the present status of the worldwide catheter market and to evaluate its potential over the five-year period from 2011 to 2016. An assessment of the global catheter market was performed while considering all of its important segments (i.e., cardiovascular, urological, neurovascular, intravenous, and specialty catheters).

 

REASONS FOR DOING THE STUDY

 

Catheterization procedures have steadily increased as interventional and less-invasive procedures have become more popular. Catheters are vital to the completion of many procedures, and some procedures or interventions, particularly in cardiovascular surgery and neurosurgery, could not be done without the use of catheters. In conducting this study, BCC was interested in determining the areas of catheter applications poised for growth and the reasons for their growth. New products and their future impact on the market were also assessed.

 

SCOPE OF REPORT

 

BCC investigated the current catheter market and based projections of total, geographic, and type of product market revenues through 2016 based on current and historical usage, geographical and socio/economic market trends, and new applications and products.

 

The scope of this study encompasses the six major application segments of the catheter market. BCC Research analyzes each type of catheter segment, determines its current market status, examines its impact on future markets, and presents growth forecasts over the next five years. Catheter material analysis, regulatory issues, and the latest technological trends are also covered. Other influential factors such as patents and company profiles are discussed.

 

METHODOLOGY

 

Both primary and secondary research methodologies were used in this report. BCC Research developed an analysis of each segment of the catheter industry depending on applications, using a historical base year of 2010. Estimated values used are based on manufacturers' net revenues.

 

INTENDED AUDIENCE

 

This study will be of interest to catheter and device manufacturers, catheter material manufacturers, and venture capitalists and financial institutions involved in the healthcare industry.

 

INFORMATION SOURCES

 

Major sources of primary research information include the World Health Organization (WHO), U.S. Centers for Disease Control (CDC), and the Organization for Economic Cooperation and Development (OECD). Secondary research sources include industry association and company press releases, company websites, financial and trade information, interviews with industry personnel, and government sources.

 

ANALYST CREDENTIALS

 

Peggy S. Lehr is the BCC Research analyst of this report. Ms. Lehr has worked with the publishing arms of for-profit and not-for-profit organizations, and she specializes in marketing reports on the medical industry.

 

 

 

 

TABLE OF CONTENTS

 

CHAPTER ONE: INTRODUCTION 1

STUDY GOALS AND OBJECTIVES . 1

REASONS FOR DOING THE STUDY 1

SCOPE OF REPORT 1

METHODOLOGY . 1

INTENDED AUDIENCE 2

INFORMATION SOURCES . 2

ANALYST CREDENTIALS 2

RELATED BCC REPORTS 2

BCC ONLINE SERVICES 3

DISCLAIMER . 3

CHAPTER TWO: SUMMARY 4

SUMMARY TABLE: GLOBAL CATHETER MARKET, BY REGION,

THROUGH 2016 ($ MILLIONS). 5

SUMMARY FIGURE GLOBAL CATHETER MARKET, BY REGION,

2011 AND 2016 (%) 5

SUMMARY FIGURE (CONTINUED) . 6

CHAPTER THREE: OVERVIEW OF GLOBAL CATHETER INDUSTRY . 7

CATHETER DEVELOPMENT 7

CATHETER CONSTRUCTION . 7

CATHETER APPLICATIONS 8

TYPES OF CATHETERS . 9

CARDIOVASCULAR CATHETERS 9

Use of Cardiovascular Catheters 9

Diagnostic Procedures and Cardiac Catheterization . 10

Therapeutic Procedures . 10

TABLE 1 INDICATIONS FOR CARDIAC CATHETERIZATION 10

TABLE 2 TYPES OF CARDIAC CATHETERS 11

Angiography Catheters . 11

Angiographic Catheter Features 11

EP Catheters 12

Cardiac Ablation Catheters 12

PCI Catheters 12

PCI and Stent Placement . 13

TABLE 3 PCI PROCEDURES . 13

Rapid Exchange Balloon Catheters 14

Over–the-Wire PCI Catheters . 14

Guiding Catheter . 14

Possible Complications 14

UROLOGICAL CATHETERS 15

Development of the Foley Catheter 15

Type of Urinary Catheterization . 16

Intermittent Catheterization . 16

Possible Complication of Intermittent

Catheters 16

Indwelling Catheterization. 17

Possible Complications from Indwelling

Catheters 17

Suprapubic Catheterization . 17

Possible Complications from Suprapubic

Catheterization 18

Male External Condom Catheterization 18

Possible Complications From Urinary Catheter Use . 19

NEUROVASCULAR CATHETERS . 19

INTRAVENOUS (IV) CATHETERS . 20

Single-Lumen Catheters . 20

Multi-Lumen Catheter 21

Specialty IV Catheters 21

Peripheral Vein Catheter . 21

Central Venous Catheter (CVC) . 21

Tunneling Insertion 22

Implantation Insertion . 22

Advantages to Central Venous Catheters . 22

Peripherally Inserted Central Catheters (PICCs) . 23

Advantages of PICC Lines 23

Possible Complications due to IV Catheters 23

TABLE 4 COMPLICATIONS DUE TO IV CATHETERS 23

TABLE 4 (CONTINUED) . 24

SPECIALTY CATHETERS 24

Thermodilution Catheters . 24

Suction Catheters 25

Oximetry Catheters . 25

END-USER PREFERENCES . 26

SIZE OF CATHETER 26

MATERIAL USED . 26

COATING . 27

LENGTH OF TIME CATHETER IS IN THE BODY . 27

INFECTION RATE 27

COST . 28

CHAPTER FOUR: CATHETERS AND WORLD DEMOGRAPHICS 29

CATHETER-ASSOCIATED INFECTIONS FROM SELECTED

PROCEDURES 29

TABLE 5 GLOBAL TRENDS IN CATHETER-ASSOCIATED

INFECTIONS BY ESTIMATED NUMBER OF INFECTIONS PER

PROCEDURE TYPE, 2006-2009 (THOUSANDS) 29

CORONARY PROCEDURES 29

TABLE 6 SELECTED WORLDWIDE CORONARY PROCEDURES,

2007* (PER 100,000 POPULATIONS) . 30

WORLDWIDE ECONOMIC DEMOGRAPHICS . 30

TABLE 7 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF

GDP BY COUNTRY, 2003-2009* (%) 31

WORLDWIDE POPULATION GROWTH . 32

CHAPTER FIVE: CATHETER MATERIALS . 33

TABLE 8 CHARACTERISTICS OF CATHETER MATERIALS . 33

KEY CHARACTERISTICS . 33

SURFACE CHARACTERISTICS 34

CATHETER USE IN ADVANCED IMAGING . 34

MRA . 34

OCT 35

RADIOPACITY IN CATHETERS . 35

Determining Appropriate Properties of Radiopaque

Catheters 36

Economics of Radiopacity 36

COMPONENT MATERIALS 37

LATEX 37

Latex Allergic Reactions 37

SILICONE 37

Silicone Catheter Characteristics . 38

Disadvantage of Silicone Catheters 38

Cost Considerations for Silicone Catheters 38

POLYTETRAFLUOROETHYLENE (PTFE) 38

Uses 39

Cost Considerations . 39

POLYURETHANE (PU) 39

Uses 39

Cost Considerations . 40

POLYVINYL CHLORIDE (PVC) . 40

Uses 40

Cost Considerations . 40

POLYETHYLENE 40

Uses 40

Cost Considerations . 40

CATHETER COATINGS 41

SILICONE ELASTOMER 41

HYDROPHILIC COATING . 41

ANTIMICROBIAL COATING . 41

Combating UTI 42

Combining Hydrophilic and Antimicrobial Coatings . 42

Silver Coating 42

ADVANTAGES AND DISADVANTAGES OF CATHETER

MATERIALS 42

TABLE 9 ADVANTAGES AND DISADVANTAGES OF CATHETER

MATERIALS 43

CHAPTER SIX: ANALYSIS OF THE GLOBAL CATHETER MARKET 44

FACTORS INFLUENCING MARKET GROWTH 44

FIGURE 1 FACTORS INFLUENCING THE MEDICAL DEVICE

MARKET 44

DEMOGRAPHIC TRENDS . 45

SURGICAL AND MEDICAL TRENDS . 45

PCI Versus CABG 45

Combined Therapies 46

Expansion of Microcatheter Use . 46

CATHETER REUSE 46

PRODUCT DISTRIBUTION . 46

REIMBURSEMENT AND REGULATION TRENDS. 46

Global Financial Conditions 47

Third-party Coverage and Reimbursement 47

Global Cost Containment 48

LEADING MANUFACTURERS 48

TABLE 10 TOTAL REVENUES OF KEY CATHETER

MANUFACTURERS, 2009 AND 2010 ($ MILLIONS) . 49

MERGERS/ACQUISITIONS IN THE CATHETER MARKET . 49

TABLE 11 MERGERS/ACQUISITIONS IN THE GLOBAL CATHETER

MARKET 2007-2011 50

KEY MARKET DRIVERS 50

INCREASE IN PROCEDURES HAS LED TO INCREASED

DEMAND FOR 50

CATHETERS 50

INCREASED DEMAND FOR DISPOSABLE CATHETERS

DUE TO RISK OF INFECTION AND TRANSMITTABLE

DISEASE . 51

NEW TECHNOLOGIES IN CATHETER DESIGN HAVE

INCREASED CATHETER USE . 51

INCREASE IN MINIMALLY INVASIVE PROCEDURES

REQUIRING CATHETERS HAS EXPANDED SALES . 51

ADVANCES IN IMAGING TECHNOLOGY HAVE LED TO

NEW APPLICATIONS REQUIRING THE USE OF

CATHETERS 52

KEY MARKET RESTRAINTS . 52

PRICE EROSIONS DUE TO FIERCE COMPETITION ARE

SHRINKING . 52

REVENUES 52

LONGER APPROVAL TIMES ARE RESULTING IN DELAYED

LAUNCHES OF NEW PRODUCTS 53

REIMBURSEMENT ISSUES HAVE AFFECTED THE USE OF . 53

TECHNOLOGICALLY ADVANCED CATHETERS 53

EXPERIENCED PHYSICIANS OFTEN ARE RELUCTANT TO

ACCEPT NEW DEVICE TECHNOLOGIES . 53

GLOBAL CATHETER REVENUE ANALYSIS . 53

TABLE 12 PROJECTED GLOBAL CATHETER MARKET BY

SEGMENT, THROUGH 2016 ($ MILLIONS) . 54

CARDIOVASCULAR CATHETERS 54

KEY MARKET CHALLENGES . 55

Pharmacological Approaches Could Threaten Catheter

Demand . 55

Lack of Clinical Data Is Hindering Acceptance of Newer

Catheters by Physicians and Healthcare Purchasing

Organizations . 55

KEY MARKET DRIVERS FOR THE CARDIOVASCULAR

SEGMENT 55

Increases in the Incidence of Cardiovascular Diseases is

Driving the Number of Procedures 55

Popularity of Angioplasty and Stent Placement over

Bypass Surgery Is Leading to an Increase in the Use of

Cardiac Catheters 56

Angiography Is Driving the Increase in the Number of

Diagnostic Procedures 56

Interventional Cardiac Procedures Can Be More Effective

than Pharmaceutical-based Therapies 57

KEY MARKET RESTRAINTS IN THE CARDIOVASCULAR

MARKET . 57

Constant Price Erosion Is Leading to Decreased Revenues 57

Decrease in Restenosis is Affecting the Number of Stent

Procedures Performed 57

Catheter Usages Is Restrained due to Low

Reimbursement Rates 58

CATHETER USE IN CONJUNCTION WITH STENT

PLACEMENT 58

Exit of Cordis from Stent Market . 59

CARDIOVASCULAR CATHETER REVENUE ANALYSIS 59

TABLE 13 PROJECTED GLOBAL MARKET FOR CARDIOVASCULAR

CATHETERS BY TYPE, THROUGH 2016 ($ MILLIONS). 60

Angiography . 60

EP Mapping Catheters 60

Balloon Catheters 61

Rapid-exchange Catheters 61

Guiding Catheters . 61

Intravascular Ultrasound Catheters (IVUS) 62

MARKET SHARES BY COMPANY 62

UROLOGICAL SEGMENT 62

Market Challenges 63

Market Drivers 63

Global Aging of the Population 63

Catheters with Antimicrobial Coatings Are

Increasing confidence in the Use of Catheters . 63

Urological Catheter Market Revenues . 64

Intermittent Catheter Revenues 64

Indwelling Catheter Revenues . 64

TABLE 14 PROJECTED GLOBAL MARKET FOR UROLOGICAL

CATHETERS, BY TYPE, THROUGH 2016 ($ MILLIONS) 64

FIGURE 2 PROJECTED GLOBAL MARKET SHARE FOR

UROLOGICAL CATHETERS, BY COMPANY, 2010 (%) . 65

INTRAVENOUS . 65

TABLE 15 PROJECTED GLOBAL MARKET FOR INTRAVENOUS

CATHETERS BY TYPE, THROUGH 2016 ($ MILLIONS). 66

FIGURE 3 GLOBAL MARKET SHARE FOR IV CATHETERS, BY

COMPANY, 2010 (%) 66

FIGURE 3 (CONTINUED) 67

NEUROVASCULAR SEGMENT . 67

Key Market Challenges . 67

Cost of Neurovascular Catheters . 67

Availability of Pharmacological Treatment Options . 68

Shortage of Qualified Professionals to Perform

Surgeries 68

Key Market Drivers . 68

Enhanced Diagnostic and Imaging Technologies

Are Creating New Areas of Treatment . 68

Stenting and Aneurysm Treatments Are Increasing

Microcatheter Use . 68

New Catheter Technologies Are Improving

Procedures and Increasing Demand . 69

Expanding Market for Unmet Treatment Options . 69

Neurovascular Catheter Market Revenues 69

TABLE 16 PROJECTED GLOBAL MARKET FOR NEUROVASCULAR

CATHETERS, THROUGH 2016 ($ MILLIONS) . 70

Market Share by Company . 70

FIGURE 4 GLOBAL NEUROVASCULAR CATHETER MARKET

SHARES BY COMPANY, 2011 (%) 71

SPECIALTY CATHETER MARKET . 71

Types of Specialty Catheters . 71

Key Market Drivers . 72

Demand for Enhanced Monitoring Devices Is

Contributing to Expanded Sales . 72

Effectiveness of Specialty Catheters Is Fueling

Growth in Use 72

Key Market Restraints 72

Increased Cost of Specialty Catheters Inhibit Sales . 72

Introduction of Competing Technologies . 72

Use of Thrombolytic Drugs . 73

Specialty Catheter Market Revenue Analysis . 73

TABLE 17 PROJECTED GLOBAL SPECIALTY CATHETER MARKET

BY TYPE, THROUGH 2016 ($ MILLIONS) . 73

Specialty Catheter Market Analysis . 73

Specialty Catheter Market Shares by Company and

Catheter Type . 74

TABLE 18 GLOBAL SPECIALTY CATHETER MARKET SHARES, BY

COMPANY AND TYPE OF CATHETER, 2010 (%) 74

GLOBAL MARKET SHARE FORECAST BY TYPE OF CATHETER . 75

FIGURE 5 PERCENT OF MARKET SHARE BY TYPE OF CATHETER

2011 AND 2016 (%) 75

FIGURE 5 (CONTINUED) 76

CONSEQUENCES OF THE ONGOING GLOBAL ECONOMIC

RECESSION 76

PROJECTIONS FOR GLOBAL CATHETER MARKET BY REGION 76

TABLE 19 PROJECTED GLOBAL CATHETER MARKET BY REGION,

THROUGH 2016 ($ MILLIONS) 77

MARKET REVENUE, BY REGION 77

Reusable Catheter Use in World Market . 77

GEOGRAPHIC MARKET SHARE BY 2016 . 78

EMERGING TECHNOLOGIES . 78

BIOABSORBABLE STENTS . 78

BIFURCATED STENTS 79

UROVALVE INC. . 79

VOLCANO CORPORATION . 80

CHAPTER SEVEN: THE AMERICAS CATHETER MARKET . 81

GDP AND PERCENT SPENT ON HEALTHCARE IN THE

AMERICAS 81

TABLE 20 GDP AND EXPENDITURE ON HEALTHCARE AS A SHARE

OF GDP IN THE AMERICAS, 2009 . 81

CATHETER MARKET IN THE AMERICAS 81

TABLE 21 PROJECTED AMERICAS MARKET FOR CATHETERS BY

COUNTRY, THROUGH 2016 ($ MILLIONS) 82

REVENUE ANALYSIS FOR THE AMERICAS' CATHETER

MARKET, BY TYPE OF CATHETER . 82

TABLE 22 PROJECTED AMERICAS MARKET FOR CATHETERS BY

TYPE, THROUGH 2016 ($ MILLIONS) 82

THE CANADIAN MARKET . 83

THE MEXICAN MARKET . 83

THE LATIN AMERICAN MARKET 83

THE SOUTH AMERICAN MARKET 83

THE U.S. MARKET 83

U.S. ECONOMIC CONDITIONS 84

EFFECTS OF HEALTHCARE REFORM IN THE U.S 84

REIMBURSEMENT. 84

Denial of Reimbursement in U.S. . 85

U.S. REGULATIONS . 85

U.S. Regulations and Reprocessing 85

CARDIOVASCULAR DISEASE 86

TABLE 23 U.S. RATES OF CARDIOVASCULAR PROCEDURES, 2007-

2009 (THOUSANDS) 86

TRENDS IN PROCEDURE USAGE . 86

COSTS OF HEART DISEASE IN THE U.S. 87

REVENUE ANALYSIS FOR CARDIOVASCULAR CATHETERS IN

THE AMERICAS . 87

TABLE 24 PROJECTED AMERICAS MARKET FOR

CARDIOVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) . 87

AMERICAS MARKET TRENDS IN CARDIOVASCULAR

CATHETERS 88

URINARY CATHETERS 88

TABLE 25 PROJECTED AMERICAS MARKET FOR URINARY

CATHETERS, THROUGH 2016 ($ MILLIONS) . 88

AMERICAS MARKET TRENDS IN URINARY CATHETERS . 88

INTRAVENOUS CATHETERS 89

TABLE 26 PROJECTED AMERICAS MARKET FOR INTRAVENOUS

CATHETERS, THROUGH 2016 ($ MILLIONS) . 90

AMERICAS MARKET TRENDS FOR INTRAVENOUS

CATHETERS 90

NEUROVASCULAR . 90

TABLE 27 PROJECTED AMERICAS MARKET FOR

NEUROVASCULAR CATHETERS, THROUGH 2016 ($ MILLIONS) 91

AMERICAS MARKET TRENDS FOR NEUROVASCULAR

CATHETERS 91

SPECIALTY 91

TABLE 28 PROJECTED AMERICAS MARKET FOR SPECIALTY

CATHETERS, THROUGH 2016 ($ MILLIONS) . 92

AMERICAS MARKET TRENDS FOR SPECIALTY

CATHETERS 92

CHAPTER EIGHT: THE EUROPEAN, MIDDLE EAST, RUSSIAN, AND

AFRICAN CATHETER MARKET 93

WESTERN EUROPEAN HEALTHCARE SYSTEMS. 93

EASTERN EUROPEAN AND AFRICAN HEALTHCARE SYSTEMS 93

MIDDLE EASTERN HEALTHCARE SYSTEMS . 94

MEDICAL TOURISM IN THE MIDDLE EAST . 94

RUSSIAN HEALTHCARE SYSTEMS . 94

HEALTHCARE IN RUSSIA 95

TABLE 29 TOTAL EXPENDITURE ON HEALTHCARE AS A SHARE

OF GDP IN SELECTED EMRA COUNTRIES, 2009 ($ MILLIONS/%) . 96

TABLE 30 PROJECTED EMRA MARKET FOR CATHETERS BY

REGION, THROUGH 2016 ($ MILLIONS) . 97

TABLE 31 PROJECTED EMRA MARKET FOR CATHETERS BY TYPE,

THROUGH 2016 ($ MILLIONS). 98

GOVERNMENT REGULATIONS . 98

MARKET GROWTH IN EMRA COUNTRIES 98

ECONOMIC CONDITIONS . 99

CARDIOVASCULAR MARKET . 99

TABLE 32 PROJECTED EMRA MARKET FOR CARDIOVASCULAR

CATHETERS, THROUGH 2016 ($ MILLIONS) . 100

TRENDS IN THE EMRA CARDIOVASCULAR CATHETER

MARKET . 100

UROLOGY CATHETER MARKET 100

TABLE 33 PROJECTED EMRA MARKET FOR UROLOGICAL

CATHETERS, THROUGH 2016 ($ MILLIONS) . 101

TRENDS IN THE EMRA UROLOGICAL CATHETER MARKET 101

INTRAVENOUS CATHETER MARKET . 101

TABLE 34 PROJECTED EMRA MARKET FOR INTRAVENOUS

CATHETERS, THROUGH 2016 ($ MILLIONS) . 101

TRENDS IN THE EMRA INTRAVENOUS CATHETER

MARKET . 102

NEUROVASCULAR CATHETER MARKET 102

TABLE 35 PROJECTED EMRA MARKET FOR NEUROVASCULAR

CATHETERS, THROUGH 2016 ($ MILLIONS) . 102

TRENDS IN THE EMRA NEUROVASCULAR CATHETER

MARKET . 102

SPECIALTY CATHETER MARKET . 103

TABLE 36 PROJECTED EMRA MARKET FOR SPECIALTY

CATHETERS, THROUGH 2016 ($ MILLIONS) . 103

TRENDS IN THE EMRA SPECIALTY CATHETER MARKET 103

CHAPTER NINE: THE ASIAN CATHETER MARKET . 104

REGIONAL ECONOMIC CONSIDERATIONS 104

TABLE 37 PROJECTED ASIAN CATHETER MARKET, THROUGH

2016 ($ MILLIONS) . 104

GDP AND GROWTH RATES . 105

TABLE 38 GDP OF SELECTED ASIAN COUNTRIES, GDP GROWTH

RATE, PERCENT OF GDP DEVOTED TO HEALTHCARE 105

REGULATIONS AND HEALTHCARE COVERAGE IN THE

AUSTRALIAN MARKET . 105

Health Insurance in Australia 106

REGULATIONS AND HEALTHCARE COVERAGE IN THE

JAPANESE MARKET 106

REGULATIONS AND HEALTHCARE COVERAGE IN THE

INDIAN MARKET 106

Medical Insurance in India . 107

Growth of the Indian Healthcare Industry 107

REGULATIONS AND HEALTHCARE COVERAGE IN THE

CHINESE MARKET . 107

Medical Device Regulations 107

Chinese Healthcare Institutions . 108

Rural and Urban Healthcare Services 108

ASIAN CATHETER MARKET BY TYPE OF PRODUCT 109

TABLE 39 PROJECTED ASIAN CATHETER MARKET BY PRODUCT

TYPE, THROUGH 2016 ($ MILLIONS) 109

CARDIOVASCULAR MARKET 109

TABLE 40 PROJECTED ASIAN CARDIOVASCULAR CATHETER

MARKET, THROUGH 2016 ($ MILLIONS) . 110

Trends in the Asian Cardiovascular Catheter Market 110

UROLOGY CATHETER MARKET . 110

TABLE 41 PROJECTED ASIAN UROLOGY CATHETER MARKET,

THROUGH 2016 ($ MILLIONS). 111

Trends in the Asian Urological Catheter Market 111

INTRAVENOUS CATHETER MARKET 111

TABLE 42 PROJECTED ASIAN INTRAVENOUS CATHETER MARKET,

THROUGH 2016 ($ MILLIONS). 111

Trends in the Asian IV Catheter Market . 112

NEUROVASCULAR CATHETER MARKET 112

TABLE 43 PROJECTED ASIAN NEUROVASCULAR CATHETER

MARKET, THROUGH 2016 ($ MILLIONS) . 112

Trends in the Asian Neurological Catheter Market 112

SPECIALTY CATHETER MARKET . 113

TABLE 44 PROJECTED ASIAN SPECIALTY CATHETER MARKET,

THROUGH 2016 ($ MILLIONS). 113

Trends in the Asian Specialty Catheter Market 113

CHAPTER TEN: PATENT ANALYSIS 114

GLOBAL CATHETER PATENT APPLICATIONS, 2008-2011 114

TABLE 45 GLOBAL CATHETER PATENT APPLICATIONS, 2008-2011 . 114

CATHETER PATENT ACTIVITY BY ASSIGNEE . 115

TABLE 46 CATHETER PATENT APPLICATION ACTIVITY BY

ASSIGNEE, JANUARY 2008-SEPTEMBER 2011 (NUMBER OF

PATENTS) 115

TABLE 46 (CONTINUED) . 116

CARDIOVASCULAR CATHETER PATENTS 116

TABLE 47 CARDIOVASCULAR CATHETER PATENTS BY TYPE,

JANUARY 2008-SEPTEMBER 2011 116

TABLE 48 CARDIAC CATHETER PATENTS, NOVEMBER 2011-

JANUARY 2008 . 117

TABLE 48 (CONTINUED) . 118

TABLE 48 (CONTINUED) . 119

TABLE 48 (CONTINUED) . 120

TABLE 49 BALLOON CATHETER PATENTS, APRIL 2011-JANUARY 2008. 120

TABLE 49 (CONTINUED) . 121

TABLE 50 CARDIAC GUIDE CATHETER PATENTS, NOVEMBER 2011-JANUARY 2008 121

TABLE 51 CARDIAC GUIDEWIRE PATENTS, 2010 . 122

UROLOGY CATHETER PATENTS . 122

IV CATHETER PATENTS . 122

TABLE 52 IV CATHETER PATENTS BY TYPE, JANUARY 2008- SEPTEMBER 2011 122

TABLE 53 IV CATHETER PATENTS, JUNE 2009-SEPTEMBER 2008 123

SPECIALTY CATHETER PATENTS 123

TABLE 54 SPECIALTY CATHETER PATENTS BY TYPE, JANUARY 2008-SEPTEMBER 2011 . 124

TABLE 55 SPECIALTY CATHETER PATENTS, OCTOBER 2011- JANUARY 2008 . 124

TABLE 55 (CONTINUED) . 125

CATHETER COATINGS 126

TABLE 56 CATHETER COATING PATENTS, JANUARY 2008- SEPTEMBER 2011 126

TABLE 57 CATHETER COATING PATENTS, JULY 2011-JUNE 2009 126

TABLE 57 (CONTINUED) . 127

CHAPTER ELEVEN: COMPANY DIRECTORY 128

ABBOTT LABORATORIES 128

BUSINESS OVERVIEW 128

FINANCIAL . 128

PRODUCTS 129

TABLE 58 ABBOTT LABORATORIES CATHETER PRODUCTS . 129

ANGIODYNAMICS 129

BUSINESS OVERVIEW 129

FINANCIALS . 130

PRODUCTS 130

TABLE 59 ANGIODYNAMICS CATHETER PRODUCTS 130

ASTRA TECH INC., UROLOGY DIVISION . 130

BUSINESS OVERVIEW 131

FINANCIALS . 131

PRODUCTS 131

TABLE 60 ASTRA TECH CATHETER PRODUCTS . 131

B. BRAUN MELSUNGEN AG . 132

BUSINESS OVERVIEW 132

FINANCIALS . 132

PRODUCTS 132

TABLE 61 B. BRAUN CATHETER PRODUCTS . 132

TABLE 61 (CONTINUED) . 133

BECTON DICKINSON & CO. . 133

BUSINESS OVERVIEW 133

FINANCIALS . 134

PRODUCTS 134

TABLE 62 BD CATHETER PRODUCTS . 134

BOSTON SCIENTIFIC . 134

BUSINESS OVERVIEW 135

FINANCIALS . 135

PRODUCTS 135

TABLE 63 BOSTON SCIENTIFIC CATHETER PRODUCTS 135

TABLE 63 (CONTINUED) . 136

CARDINAL HEALTH . 136

BUSINESS OVERVIEW 136

FINANCIALS . 137

PRODUCTS 137

TABLE 64 CARDINAL HEALTH CATHETER PRODUCTS 137

CAREFUSION CORP. 137

BUSINESS OVERVIEW 138

FINANCIALS . 138

PRODUCTS 138

TABLE 65 CAREFUSION CATHETER PRODUCTS 138

CODMAN & SHURTLEFF (DEPUY) 138

BUSINESS OVERVIEW 138

FINANCIALS . 139

PRODUCTS 139

TABLE 66 CODMAN & SHURTLEFF CATHETER PRODUCTS 139

COLOPLAST GROUP 139

FINANCIALS . 140

PRODUCTS 140

TABLE 67 COLOPLAST CATHETER PRODUCTS 140

COOK MEDICAL 140

BUSINESS OVERVIEW 140

FINANCIALS . 141

PRODUCTS 141

TABLE 68 COOK MEDICAL CATHETER PRODUCTS . 141

TABLE 68 (CONTINUED) . 142

COVIDIEN 142

BUSINESS OVERVIEW 142

FINANCIALS . 142

PRODUCTS 143

TABLE 69 COVIDIEN CATHETER PRODUCTS 143

C. R. BARD . 144

BUSINESS OVERVIEW 144

FINANCIALS . 144

PRODUCTS 144

TABLE 70 C. R. BARD CATHETER PRODUCTS 144

TABLE 70 (CONTINUED) . 145

TABLE 70 (CONTINUED) 146

EDWARDS LIFESCIENCES . 146

BUSINESS OVERVIEW 146

FINANCIALS . 146

PRODUCTS 147

TABLE 71 EDWARDS LIFESCIENCES CATHETER PRODUCTS 147

EV3 ENDOVASCULAR INC. (COVIDIEN) 147

BUSINESS OVERVIEW 147

FINANCIALS . 147

PRODUCTS 148

TABLE 72 EV3 CATHETER PRODUCTS 148

GOODMAN CO. LTD 148

BUSINESS OVERVIEW 148

FINANCIALS . 149

PRODUCTS 149

TABLE 73 GOODMAN CATHETER PRODUCTS . 149

HOLLISTER 149

BUSINESS OVERVIEW 149

FINANCIALS . 149

PRODUCTS 150

TABLE 74 HOLLISTER CATHETER PRODUCTS . 150

HOSPIRA INC. . 150

BUSINESS OVERVIEW 150

FINANCIALS . 150

PRODUCTS 150

TABLE 75 HOSPIRA CATHETER PRODUCTS 150

ICU MEDICAL 151

BUSINESS OVERVIEW 151

FINANCIALS . 151

PRODUCTS 151

TABLE 76 ICU MEDICAL CATHETER PRODUCTS . 151

INTEGRA LIFE SCIENCES 152

BUSINESS OVERVIEW 152

FINANCIALS . 152

PRODUCTS 152

TABLE 77 INTEGRA LIFESCIENCES CATHETER PRODUCTS 152

JOHNSON & JOHNSON . 152

BUSINESS OVERVIEW 153

FINANCIALS . 153

PRODUCTS 153

TABLE 78 JOHNSON & JOHNSON CATHETER PRODUCTS 153

TABLE 78 (CONTINUED) . 154

KIMBERLY CLARK HEALTHCARE 154

BUSINESS OVERVIEW 154

FINANCIALS . 155

PRODUCTS 155

TABLE 79 KIMBERLY CLARK HEALTHCARE CATHETER PRODUCTS 155

MEDCOMP 155

BUSINESS OVERVIEW 155

FINANCIALS . 155

PRODUCTS 156

TABLE 80 MEDCOMP CATHETER PRODUCTS . 156

MEDLINE INDUSTRIES . 156

BUSINESS OVERVIEW 156

FINANCIALS . 157

PRODUCTS 157

TABLE 81 MEDLINE CATHETER PRODUCTS . 157

MEDRAD (BAYER AG) 157

BUSINESS OVERVIEW 157

FINANCIALS . 158

PRODUCTS 158

TABLE 82 MEDRAD CATHETER PRODUCTS 158

MEDTRONIC 158

BUSINESS OVERVIEW 158

FINANCIALS . 159

PRODUCTS 159

TABLE 83 MEDTRONIC CATHETER PRODUCTS . 159

MERIT MEDICAL SYSTEMS 160

BUSINESS OVERVIEW 160

FINANCIALS . 160

PRODUCTS 160

TABLE 84 MERIT MEDICAL CATHETER PRODUCTS 160

TABLE 84 (CONTINUED) . 161

NAVILYST MEDICAL 161

BUSINESS OVERVIEW 161

FINANCIALS . 161

PRODUCTS 162

TABLE 85 NAVILYST MEDICAL CATHETER PRODUCTS . 162

PULSION MEDICAL AG . 162

BUSINESS OVERVIEW 162

FINANCIALS . 162

PRODUCTS 163

TABLE 86 PULSION MEDICAL SYSTEMS CATHETER PRODUCTS 163

ROCHESTER MEDICAL . 163

BUSINESS OVERVIEW 163

FINANCIALS . 163

PRODUCTS 164

TABLE 87 ROCHESTER MEDICAL CATHETER PRODUCTS 164

SMITHS MEDICAL 164

BUSINESS OVERVIEW 164

FINANCIALS . 165

PRODUCTS 165

TABLE 88 SMITHS MEDICAL CATHETER PRODUCTS . 165

ST. JUDE MEDICAL 166

BUSINESS OVERVIEW 166

FINANCIALS . 166

PRODUCTS 166

TABLE 89 ST. JUDE MEDICAL CATHETER PRODUCTS . 166

TABLE 89 (CONTINUED) . 167

STRYKER 167

BUSINESS OVERVIEW 167

FINANCIALS . 168

PRODUCTS 168

TABLE 90 STRYKER CATHETER PRODUCTS . 168

TELEFLEX MEDICAL (FORMERLY ARROW INTERNATIONAL) 168

BUSINESS OVERVIEW 168

FINANCIALS . 169

PRODUCTS 169

TABLE 91 TELEFLEX CATHETER PRODUCTS . 169

TERUMO MEDICAL CORP. 170

BUSINESS OVERVIEW 170

FINANCIALS . 170

PRODUCTS 170

TABLE 92 TERUMO CATHETER PRODUCTS 170

TABLE 92 (CONTINUED) 171

VASCULAR SOLUTIONS 171

BUSINESS OVERVIEW 171

FINANCIALS . 172

PRODUCTS 172

TABLE 93 VASCULAR SOLUTIONS CATHETER PRODUCTS . 172

VOLCANO CORPORATION 172

BUSINESS OVERVIEW 172

FINANCIALS . 173

PRODUCTS 173

TABLE 94 VOLCANO CORPORATION CATHETER PRODUCTS . 173

APPENDIX: CATHETER PRODUCTS AND THEIR MANUFACTURERS . 174

TABLE 95 CATHETER PRODUCTS BY APPLICATION, TYPE, BRAND

NAME, AND MANUFACTURER . 174

TABLE 95 (CONTINUED) . 175

TABLE 95 (CONTINUED) . 176

TABLE 95 (CONTINUED) . 177

TABLE 95 (CONTINUED) . 178

TABLE 95 (CONTINUED) 179

TABLE 95 (CONTINUED) . 180

TABLE 95 (CONTINUED) . 181

TABLE 95 (CONTINUED) . 182

TABLE 95 (CONTINUED) . 183

TABLE 95 (CONTINUED) . 184

TABLE 95 (CONTINUED) . 185

TABLE 95 (CONTINUED) . 186

TABLE 95 (CONTINUED) . 187

TABLE 95 (CONTINUED) . 188

TABLE 95 (CONTINUED) . 189

TABLE 95 (CONTINUED) . 190

TABLE 95 (CONTINUED) 191

 

To order this report:

Medical Equipment and Supply Industry: Global Markets for Catheters

More Market Research Report

Check our Industry Analysis and Insights

 

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016 Laboratory glassware ... in laboratories. These may range from microscope slides to ... is made from borosilicate glass because of its low ... the other hand, started gaining popularity over the past ... to replace glass with plastic in several applications due ...
(Date:2/11/2016)... -- Governor Andrew M. Cuomo today announced a major expansion ... Western New York . This announcement, made ... includes a major expansion of Athenex,s North American headquarters ... , as well as the creation of a state-of-the-art, ... . The combined projects are expected to yield ...
(Date:2/11/2016)... 11, 2016  NOIT™ Research LLC, a private, leading-edge ... Change" campaign to assist needy families in obtaining one ... sold between February 10, 2016 and March 31, 2016, ... family. The NOIT is an auditory stimulus that plays ... language skills. Beth Shier , NOIT ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... As a former television ... a demanding job, and no time to decompress, Rabinowitz found herself drawn to a ... meditation for its impact on her life, implementing a 20-minute-per-day meditation practice with her ...
(Date:2/12/2016)... ... 12, 2016 , ... Itopia, a leader in cloud services ... Intelligence Platform (CIP) into Cielo®, a discovery, migration and cloud orchestration engine. This ... small and medium business (SMB) clients. , In recent years, BI ...
(Date:2/12/2016)... ... 2016 , ... The Jones Agency, a family owned insurance company with offices ... cooperative charity drive with the Tarrant Area Food Bank in the hopes of alleviating ... in need, the Tarrant County Food Bank offers hope and security to the one ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Donor Network West, ... California and Nevada, announced a partnership with San Ramon Regional Medical Center. Under the ... hospital’s facilities as a way to accommodate a more certain time frame for donor ...
(Date:2/12/2016)... NY (PRWEB) , ... February 12, 2016 , ... ... of “Revolutionizing Cancer Care.” , The print component of “Revolutionizing Cancer ... Dallas, Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation of approximately ...
Breaking Medicine News(10 mins):